title: Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors.
abstract: Polymorphonuclear leukocyte (PMN) chemotaxis has been examined under conditions which allow phase microscope observations of cells responding to controlled gradients of chemotactic factors. With this visual assay, PMNs can be seen to orient rapidly and reversibly to gradients of N-formylmethionyl peptides. The level of orientation depends upon the mean concentration of peptide present as well as the concentration gradient. The response allows an estimation of the binding constant of the peptide to the cell. In optimal gradients, PMNs can detect a 1% difference in the concentration of peptide. At high cell densities, PMNs incubated with active peptides orient their locomotion away from the center of the cell population. This orientation appears to be due to inactivation of the peptides by the cells. Such inactivation in vivo could help to limit an inflammatory response.
mesh_terms: D000818:Animals; D002634:Chemotaxis, Leukocyte; D006801:Humans; D007700:Kinetics; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009504:Neutrophils / Q000166:cytology / Q000502:physiology*; D011817:Rabbits
chemical_list: D009240:N-Formylmethionine Leucyl-Phenylalanine
references.citation: J Immunol. 1974 Jun;112(6):2055-62
references.pmid: 4825785
references.citation: Exp Cell Res. 1975 Jul;93(2):420-6
references.pmid: 808419
references.citation: Proc Natl Acad Sci U S A. 1975 Feb;72(2):710-3
references.pmid: 1091931
references.citation: Proc Natl Acad Sci U S A. 1976 Jul;73(7):2439-42
references.pmid: 1065899
references.citation: Proc Natl Acad Sci U S A. 1975 Oct;72(10):4123-7
references.pmid: 1060093
references.citation: J Exp Med. 1976 May 1;143(5):1154-69
references.pmid: 1262785
references.citation: Nature. 1975 Dec 25;258(5537):723-4
references.pmid: 1207753
references.citation: J Pharmacol Exp Ther. 1975 Jul;194(1):159-64
references.pmid: 1151747
references.citation: Nature. 1975 Aug 21;256(5519):646-8
references.pmid: 1167269
references.citation: Arthritis Rheum. 1965 Oct;8(5):757-64
references.pmid: 5859551
references.citation: Biophys J. 1963 May;3(3):215-37
references.pmid: 19431324
references.citation: Exp Cell Res. 1963 Mar;30:125-38
references.pmid: 13939931
references.citation: J Exp Med. 1962 Mar 1;115:453-66
references.pmid: 13872176
references.citation: Br J Exp Pathol. 1956 Oct;37(5):477-80
references.pmid: 13374205
references.citation: J Pathol Bacteriol. 1953 Jul;66(1):135-46
references.pmid: 13109626
references.citation: Proc Natl Acad Sci U S A. 1977 Mar;74(3):1204-8
references.pmid: 265563
references.citation: Biochem Biophys Res Commun. 1977 Jan 24;74(2):810-7
references.pmid: 836328
references.citation: Biophys J. 1976 Oct;16(10):1171-82
references.pmid: 963197
references.citation: J Immunol. 1974 Jun;112(6):2047-54
references.pmid: 4596695
references.citation: Proc Natl Acad Sci U S A. 1975 Mar;72(3):1059-62
references.pmid: 1093163
references.citation: Proc Soc Exp Biol Med. 1966 Jul;122(3):831-5
references.pmid: 5918958
references.citation: J Cell Biol. 1974 Sep;62(3):594-609
references.pmid: 4855032
references.citation: Science. 1972 Jun 30;176(4042):1432-4
references.pmid: 5033651
references.citation: Exp Cell Res. 1974 May;86(1):184-7
references.pmid: 4364648
references.citation: Exp Cell Res. 1973 Jun;79(2):375-85
references.pmid: 4361082
references.citation: Z Immunitatsforsch Exp Klin Immunol. 1972 Jun;143(5):466-76
references.pmid: 4282929
references.citation: Exp Cell Res. 1974 Sep;88(1):63-73
references.pmid: 4607838
references.citation: Immunology. 1975 Jul;29(1):163-74
references.pmid: 49293
references.citation: Exp Cell Res. 1972 Jan;70(1):129-39
references.pmid: 4550354